Cytosorbents (CTSO) Tax Provisions (2012 - 2025)
Cytosorbents (CTSO) posted Tax Provisions of -$1.4 million for Q4 2025, down 251.25% on a QoQ basis from -$400000.0 in Q3 2025, and up 16.91% year-over-year from -$1.2 million in Q4 2024.
Cytosorbents (CTSO) Tax Provisions (2012 - 2025) Analysis & Trends
Cytosorbents' Tax Provisions history runs 12 years deep, the most recent figure standing at -$1.4 million for Q4 2025.
- Quarterly Tax Provisions rose 16.91% year-over-year to -$1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.5 million (down 39.58% YoY) and the FY2025 annual result came in at -$1.8 million, down 6.8% from the prior year.
- Tax Provisions was -$1.4 million for Q4 2025 at Cytosorbents, down from -$400000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at -$400000.0 in Q3 2025 and bottomed at -$1.7 million in Q4 2024.
- A 5-year average of -$1.0 million and a median of -$953162.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2021 — Tax Provisions soared 34.7% — and 2024, when it slumped 107.81%.
- Cytosorbents' Tax Provisions stood at -$736003.0 in 2021, then tumbled by 48.45% to -$1.1 million in 2022, then increased by 25.52% to -$813739.0 in 2023, then slumped by 107.81% to -$1.7 million in 2024, then climbed by 16.91% to -$1.4 million in 2025.
- Business Quant data shows CTSO's Tax Provisions at -$1.4 million in Q4 2025, -$400000.0 in Q3 2025, and -$1.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 70.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 94.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.41 Mn |
| Sep 30, 2025 | -400,000.00 |
| Dec 31, 2024 | -1.69 Mn |
| Dec 31, 2023 | -813,739.00 |
| Dec 31, 2022 | -1.09 Mn |
| Dec 31, 2021 | -736,003.00 |
| Dec 31, 2020 | -1.13 Mn |
| Dec 31, 2019 | -1.09 Mn |
| Dec 31, 2018 | -619,546.00 |
| Dec 31, 2017 | -676,739.00 |
| Dec 31, 2016 | -318,550.00 |
| Dec 31, 2015 | -324,606.00 |
| Dec 31, 2012 | -391,756.00 |